Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
CENTRAL EUROPEAN DISTRIBUTION CORP (CEDC)
|
Add to portfolio |
|
|
|
| Price: |
$5.52
| | Metrics |
| OS: |
10
|
k
| |
|
|
| Market cap: |
$55.2
|
k
| |
|
|
|
|
|
| |
|
|
|
|
|
| | | |
| | | | | |
| TTM Valuation | | | |
|
|
|
| |
|
|
|
|
|
| |
|
|
| EPS |
| |
|
|
|
BVPS
|
($22,322.30)
| |
0.00
|
x P/B
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
| In millions, except per share items | Dec-31-12 | Dec-31-11 | Dec-31-10 | Dec-31-09 | Dec-31-08 | Dec-31-07 | Dec-31-06 | Dec-31-05 |
| Revenues | 1,745.3 | 1,738.0 | 1,563.1 | 0.0 | 1,290.0 | 398.1 | 944.1 | 749.4 |
| Revenue growth | 0.4% | 11.2% | | -100.0% | 224.1% | -57.8% | 26.0% | 29.0% |
| Cost of goods sold | 488.3 | 530.5 | 392.5 | 0.0 | 321.3 | 254.6 | 745.7 | 627.4 |
| Gross profit | 1,257.0 | 1,207.5 | 1,170.6 | 0.0 | 968.7 | 143.4 | 198.4 | 122.0 |
| Gross margin | 72.0% | 69.5% | 74.9% | | 75.1% | 36.0% | 21.0% | 16.3% |
| Selling, general and administrative | 282.8 | 262.2 | 235.4 | 0.0 | 114.6 | 62.9 | 106.8 | 70.4 |
| EBIT | 44.5 | 36.8 | 87.6 | 0.0 | 134.2 | 80.5 | 91.6 | 51.6 |
| EBIT margin | 2.6% | 2.1% | 5.6% | | 23.5% | 20.2% | 9.7% | 6.9% |
| Pre-tax income | -351.5 | -1,280.2 | -169.8 | 0.0 | -16.3 | 69.1 | 78.2 | 27.9 |
| Income taxes | 11.7 | 37.5 | -13.9 | 0.0 | -1.4 | -9.1 | 14.0 | 5.3 |
| Tax rate | | | 8.2% | | 8.5% | | 17.9% | 19.2% |
| Earnings from continuing ops | -363.2 | -1,325.6 | -142.5 | | -14.9 | 78.2 | 55.5 | 20.3 |
| Earnings from discontinued ops | | | -8.4 | | 22.0 | | | |
| Net income | -363.2 | -1,325.6 | -150.9 | 0.0 | -14.9 | 78.2 | 55.5 | 20.3 |
| Net margin | -20.8% | -76.3% | -9.7% | | -2.6% | 19.6% | 5.9% | 2.7% |
| |
| Diluted EPS | ($4.71) | ($18.33) | ($2.03) | $0.00 | ($0.38) | | $1.55 | $0.72 |
| Shares outstanding (diluted) | 77.1 | 72.3 | 70.3 | 54.0 | 628.5 | | 35.8 | 28.2 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|